ARTICLE | Distillery Therapeutics
Activating RIPK3 could help treat melanoma and lung cancer
July 10, 2019 11:21 PM UTC
INDICATION: Melanoma; lung cancer...
BCIQ Company Profiles
BCIQ Target Profiles
Receptor-interacting serine-threonine kinase 3 (RIPK3) (RIP3)